![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 25
Zeitschriftenartikel
Weiss, Lena 
ORCID: https://orcid.org/0000-0002-8101-3529; Stintzing, Sebastian ORCID: https://orcid.org/0000-0002-3297-5801; Stahler, Arndt ORCID: https://orcid.org/0000-0003-1041-0137; Westphalen, C. Benedikt ORCID: https://orcid.org/0000-0002-5310-3754; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Vehling-Kaiser, Ursula; Al-Batran, Salah-Edin; Heintges, Tobias; Lerchenmüller, Christian A.; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Heinrich, Kathrin ORCID: https://orcid.org/0000-0003-3580-2313; Holch, Julian Walter ORCID: https://orcid.org/0000-0002-4755-0179; Alig, Annabel ORCID: https://orcid.org/0000-0002-3922-3450; Jung, Andreas ORCID: https://orcid.org/0000-0001-5270-9108; Modest, Dominik Paul und Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321
(15. Mai 2025):
Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancer.
In: European Journal of Cancer, Bd. 221, 115399
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-8101-3529; Stintzing, Sebastian ORCID: https://orcid.org/0000-0002-3297-5801; Stahler, Arndt ORCID: https://orcid.org/0000-0003-1041-0137; Westphalen, C. Benedikt ORCID: https://orcid.org/0000-0002-5310-3754; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Vehling-Kaiser, Ursula; Al-Batran, Salah-Edin; Heintges, Tobias; Lerchenmüller, Christian A.; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Heinrich, Kathrin ORCID: https://orcid.org/0000-0003-3580-2313; Holch, Julian Walter ORCID: https://orcid.org/0000-0002-4755-0179; Alig, Annabel ORCID: https://orcid.org/0000-0002-3922-3450; Jung, Andreas ORCID: https://orcid.org/0000-0001-5270-9108; Modest, Dominik Paul und Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321
(15. Mai 2025):
Molecular hyperselection for optimal choice of first-line targeted therapy independent of primary tumor sidedness: An exploratory analysis of the randomized FIRE-3 study performed in RAS wild-type metastatic colorectal cancer.
In: European Journal of Cancer, Bd. 221, 115399
[PDF, 1MB]
Holch, Julian Walter ORCID: https://orcid.org/0000-0002-4755-0179; Ohnmacht, Alexander J.; Stintzing, Sebastian ORCID: https://orcid.org/0000-0002-3297-5801; Heinrich, Kathrin ORCID: https://orcid.org/0000-0003-3580-2313; Weiss, Lena ORCID: https://orcid.org/0000-0002-8101-3529; Probst, Victoria ORCID: https://orcid.org/0009-0008-8038-7351; Stahler, Arndt ORCID: https://orcid.org/0000-0003-1041-0137; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Kaiser, Florian; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank ORCID: https://orcid.org/0000-0001-5575-1010; Link, Hartmut ORCID: https://orcid.org/0000-0002-9659-0265; Höffkes, Heinz-Gert; Moehler, Markus; Modest, Dominik Paul; Menden, Michael P. und Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321
(2. Mai 2025):
FOLFIRI with cetuximab or bevacizumab in RAS wild-type metastatic colorectal cancer: Refining first-line treatment selection by combining clinical parameters.
In: European Journal of Cancer, Bd. 220, 115388
[PDF, 1MB]
ORCID: https://orcid.org/0000-0002-4755-0179; Ohnmacht, Alexander J.; Stintzing, Sebastian ORCID: https://orcid.org/0000-0002-3297-5801; Heinrich, Kathrin ORCID: https://orcid.org/0000-0003-3580-2313; Weiss, Lena ORCID: https://orcid.org/0000-0002-8101-3529; Probst, Victoria ORCID: https://orcid.org/0009-0008-8038-7351; Stahler, Arndt ORCID: https://orcid.org/0000-0003-1041-0137; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Kaiser, Florian; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank ORCID: https://orcid.org/0000-0001-5575-1010; Link, Hartmut ORCID: https://orcid.org/0000-0002-9659-0265; Höffkes, Heinz-Gert; Moehler, Markus; Modest, Dominik Paul; Menden, Michael P. und Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321
(2. Mai 2025):
FOLFIRI with cetuximab or bevacizumab in RAS wild-type metastatic colorectal cancer: Refining first-line treatment selection by combining clinical parameters.
In: European Journal of Cancer, Bd. 220, 115388
[PDF, 1MB]
Michl, Marlies; Taverna, Francesco; Woischke, Christine; Li, Pan; Klauschen, Frederick; Kirchner, Thomas; Heinemann, Volker ORCID: https://orcid.org/0000-0002-1349-3321; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Stahler, Arndt; Herold, Tobias Marcus; Jurinovic, Vindi; Engel, Jutta; Kumbrink, Jörg ORCID: https://orcid.org/0000-0003-4633-4105 und Neumann, Jens
(2024):
Identification of a gene expression signature associated with brain metastasis in colorectal cancer.
In: Clinical and Translational Oncology, Bd. 26: S. 1886-1895
[PDF, 848kB]
ORCID: https://orcid.org/0000-0002-1349-3321; Bergwelt-Baildon, Michael von ORCID: https://orcid.org/0000-0002-1952-052X; Stahler, Arndt; Herold, Tobias Marcus; Jurinovic, Vindi; Engel, Jutta; Kumbrink, Jörg ORCID: https://orcid.org/0000-0003-4633-4105 und Neumann, Jens
(2024):
Identification of a gene expression signature associated with brain metastasis in colorectal cancer.
In: Clinical and Translational Oncology, Bd. 26: S. 1886-1895
[PDF, 848kB]
Fischer, Laura E. ORCID: https://orcid.org/0000-0001-8752-5827; Stintzing, Sebastian; Weikersthal, Ludwig Fischer von; Modest, Dominik P.; Decker, Thomas; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Kaiser, Florian; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Stauch, Martina; Scheithauer, Werner; Giessen-Jung, Clemens; Uhlig, Jens; Peuser, Bettina; Denzlinger, Claudio; Stahler, Arndt; Weiss, Lena; Heinrich, Kathrin; Held, Swantje; Jung, Andreas; Kirchner, Thomas und Heinemann, Volker
(2022):
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
In: British Journal of Cancer, Bd. 127, Nr. 5: S. 836-843
[PDF, 788kB]
ORCID: https://orcid.org/0000-0001-8752-5827; Stintzing, Sebastian; Weikersthal, Ludwig Fischer von; Modest, Dominik P.; Decker, Thomas; Kiani, Alexander ORCID: https://orcid.org/0000-0002-2494-4087; Kaiser, Florian; Al-Batran, Salah-Eddin; Heintges, Tobias; Lerchenmüller, Christian; Kahl, Christoph; Seipelt, Gernot; Kullmann, Frank; Stauch, Martina; Scheithauer, Werner; Giessen-Jung, Clemens; Uhlig, Jens; Peuser, Bettina; Denzlinger, Claudio; Stahler, Arndt; Weiss, Lena; Heinrich, Kathrin; Held, Swantje; Jung, Andreas; Kirchner, Thomas und Heinemann, Volker
(2022):
Efficacy of FOLFIRI plus cetuximab vs FOLFIRI plus bevacizumab in 1st-line treatment of older patients with RAS wild-type metastatic colorectal cancer: an analysis of the randomised trial FIRE-3.
In: British Journal of Cancer, Bd. 127, Nr. 5: S. 836-843
[PDF, 788kB]
Raschzok, Nathanael; Stintzing, Sebastian; Heinemann, Volker; Rauch, Geraldine; Ricke, Jens; Guckenberger, Matthias; Kurreck, Annika; Alig, Annabel H. S.; Stahler, Arndt; Bullinger, Lars; Schmelzle, Moritz; Schoening, Wenzel; Lurje, Georg; Krenzien, Felix; Haase, Oliver; Rau, Beate; Gebauer, Bernhard; Sauer, Igor M.; Pratschke, Johann und Modest, Dominik P.
(2022):
FIRE-9-PORT/AIO-KRK-0418: a prospective, randomized, open, multicenter Phase III trial to investigate the efficacy of adjuvant/additive chemotherapy in patients with definitely-treated metastatic colorectal cancer.
In: BMC Cancer, Bd. 22, Nr. 1, 359
Alig, Annabel H. S.; Heinemann, Volker; Geissler, Michael; Fischer von Weikersthal, Ludwig; Decker, Thomas; Heinrich, Kathrin; Held, Swantje; Weiss, Lena; Moosmann, Nicolas; Stahler, Arndt; Jelas, Ivan; Kurreck, Annika; Einem, Jobst C. von; Reinacher-Schick, Anke C.; Tannapfel, Andrea; Giessen-Jung, Clemens; Stintzing, Sebastian und Modest, Dominik P. von
(2022):
Exact Primary Tumor Location in mCRC: Prognostic Value and Predictive Impact on Anti-EGFR mAb Efficacy.
In: Cancers, Bd. 14, Nr. 3, 526
Kurreck, Annika; Heinemann, Volker; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kaiser, Florian; Uhlig, Jens; Schenk, Michael; Freiberg-Richter, Jens; Peuser, Bettina; Denzlinger, Claudio; Graeven, Ullrich; Heinrich, Kathrin; Held, Swantje; Stahler, Arndt; Alig, Annabel Helga Sophie; Jelas, Ivan; Einem, Jobst C. von; Stintzing, Sebastian; Giessen-Jung, Clemens und Modest, Dominik P.
(2022):
Response and Disease Dynamics in Untreated Metastatic Colorectal Cancer With Bevacizumab-Based Sequential vs. Combination Chemotherapy-Analysis of the Phase 3 XELAVIRI Trial.
In: Frontiers in Oncology, Bd. 12, 751453
Modest, Dominik Paul; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Müller, Lothar; König, Alexander Otto; Fischer von Weikersthal, Ludwig; Caca, Karel; Kretzschmar, Albrecht; Goekkurt, Eray; Haas, Siegfried; Kurreck, Annika; Stahler, Arndt; Held, Swantje; Jarosch, Armin; Horst, David; Reinacher-Schick, Anke; Kasper, Stefan; Heinemann, Volker; Stintzing, Sebastian und Trarbach, Tanja
(2022):
Panitumumab Plus Fluorouracil and Folinic Acid Versus Fluorouracil and Folinic Acid Alone as Maintenance Therapy in RAS Wild-Type Metastatic Colorectal Cancer: The Randomized PANAMA Trial (AIO KRK 0212).
In: Journal of Clinical Oncology, Bd. 40, Nr. 1: S. 72-82
Arends, Christopher Maximilian; Dimitriou, Savvina; Stahler, Arndt; Hablesreiter, Raphael; Strzelecka, Paulina M.; Stein, Catarina M.; Tilgner, Marlon; Saiki, Ryunosuke; Ogawa, Seishi; Bullinger, Lars; Modest, Dominik P.; Stintzing, Sebastian; Heinemann, Volker und Damm, Frederik
(2022):
Clonal hematopoiesis is associated with improved survival in patients with metastatic colorectal cancer from the FIRE-3 trial.
In: Blood, Bd. 139, Nr. 10: S. 1593-1597
Sommerhauser, Greta; Kurreck, Annika; Beck, Alexander; Fehrenbach, Uli; Karthaus, Meinolf; Fruehauf, Stefan; Graeven, Ullrich; Mueller, Lothar; Koenig, Alexander O.; Weikersthal, Ludwig F. v.; Goekkurt, Eray; Haas, Siegfried; Stahler, Arndt; Heinemann, Volker; Held, Swantje; Alig, Annabel H. S.; Kasper, Stefan; Stintzing, Sebastian; Trarbach, Tanja und Modest, Dominik P.
(2022):
Depth of response of induction therapy and consecutive maintenance treatment in patients with RAS wild-type metastatic colorectal cancer: An analysis of the PanaMa trial (AIO KRK 0212).
In: European Journal of Cancer, Bd. 178: S. 37-48
Stahler, Arndt; Modest, Dominik P.; Fischer von Weikersthal, Ludwig; Kaiser, Florian; Decker, Thomas; Held, Swantje; Graeven, Ullrich; Schwaner, Ingo; Denzlinger, Claudio; Schenk, Michael; Kurreck, Annika; Heinrich, Kathrin; Giessen-Jung, Clemens; Neumann, Jens; Kirchner, Thomas; Jung, Andreas; Stintzing, Sebastian und Heinemann, Volker
(2022):
First-line fluoropyrimidine plus bevacizumab followed by irinotecan-escalation versus initial fluoropyrimidine, irinotecan and bevacizumab in patients with metastatic colorectal cancer - Final survival and per-protocol analysis of the randomised XELAVIRI trial (AIO KRK 0110).
In: European Journal of Cancer, Bd. 173: S. 194-203
Heinrich, Kathrin; Lorenzen, Sylvie; Ziegler, Sonia; Huber, Tobias; Sommer, Nils und Stahler, Arndt
(2022):
Nachwuchsaktivität der Jungen Onkologie.
In: Onkologe, Bd. 28, Nr. SUPPL 1: S. 67-72
Kumbrink, Jorg; Bohlmann, Lisa; Mamlouk, Soulafa; Redmer, Torben; Peilstocker, Daniela; Li, Pan; Lorenzen, Sylvie; Alguel, Hana; Kasper, Stefan; Hempel, Dirk; Kaiser, Florian; Michl, Marlies; Bartsch, Harald; Neumann, Jens; Klauschen, Frederick; Bergwelt-Baildon, Michael von; Modest, Dominik Paul; Stahler, Arndt; Stintzing, Sebastian; Jung, Andreas; Kirchner, Thomas; Schäfer, Reinhold; Heinemann, Volker und Holch, Julian W.
(2022):
Serial Analysis of Gene Mutations and Gene Expression during First-Line Chemotherapy against Metastatic Colorectal Cancer: Identification of Potentially Actionable Targets within the Multicenter Prospective Biomarker Study REVEAL.
In: Cancers, Bd. 14, Nr. 15
[PDF, 4MB]
Fey, Theres; Erickson, Nicole ORCID: https://orcid.org/0000-0002-0473-7689; Stahler, Arndt; Muenchhoff, Maximilian; Keppler, Oliver T.; Rühlmann, Katharina; Krauss-Pfeiffer, Gabriele; Steinberg, Hannah; Graf, Alexander; Krebs, Stefan; Blum, Helmut; Khatamzas, Elham; Seynstahl, Sarah; Casuscelli, Jozefina; Markwardt, Daniel; Forstpointner, Roswitha; Schinkoethe, Timo; Bergwelt-Baildon, Michael von und Heinemann, Volker
(2022):
Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV.
In: Medical Oncology, Bd. 39, Nr. 6
[PDF, 678kB]
ORCID: https://orcid.org/0000-0002-0473-7689; Stahler, Arndt; Muenchhoff, Maximilian; Keppler, Oliver T.; Rühlmann, Katharina; Krauss-Pfeiffer, Gabriele; Steinberg, Hannah; Graf, Alexander; Krebs, Stefan; Blum, Helmut; Khatamzas, Elham; Seynstahl, Sarah; Casuscelli, Jozefina; Markwardt, Daniel; Forstpointner, Roswitha; Schinkoethe, Timo; Bergwelt-Baildon, Michael von und Heinemann, Volker
(2022):
Should routine risk reduction procedures for the prevention and control of pandemics become a standard in all oncological outpatient clinics? The prospective COVID-19 cohort study: protect-CoV.
In: Medical Oncology, Bd. 39, Nr. 6
[PDF, 678kB]
Torlot, Lucien; Jarzab, Anna; Albert, Johanna; Pok-Udvari, Agnes; Stahler, Arndt; Holch, Julian Walter; Gerlinger, Marco; Heinemann, Volker; Klauschen, Frederick; Kirchner, Thomas; Kumbrink, Jörg; Küster, Bernhard und Jung, Andreas ORCID: https://orcid.org/0000-0001-5270-9108
(2022):
Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 2: S. 669-682
[PDF, 2MB]
ORCID: https://orcid.org/0000-0001-5270-9108
(2022):
Proteomics uncover EPHA2 as a potential novel therapeutic target in colorectal cancer cell lines with acquired cetuximab resistance.
In: Journal of Cancer Research and Clinical Oncology, Bd. 149, Nr. 2: S. 669-682
[PDF, 2MB]
Stahler, Arndt; Heinemann, Volker; Schuster, Veronika; Heinrich, Kathrin; Kurreck, Annika; Giessen-Jung, Clemens; Weikersthal, Ludwig Fischer von; Kaiser, Florian; Decker, Thomas; Held, Swantje; Graeven, Ullrich; Schwaner, Ingo; Denzlinger, Claudio; Schenk, Michael; Neumann, Jens; Kirchner, Thomas; Jung, Andreas; Kumbrink, Jorg; Stintzing, Sebastian und Modest, Dominik P.
(2021):
Consensus molecular subtypes in metastatic colorectal cancer treated with sequential versus combined fluoropyrimidine, bevacizumab and irinotecan (XELAVIRI trial).
In: European Journal of Cancer, Bd. 157: S. 71-80
Heinrich, Kathrin; Modest, Dominik P.; Ricard, Ingrid; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kaiser, Florian; Graeven, Ullrich; Uhlig, Jens; Schenk, Michael; Freiberg-Richter, Jens; Peuser, Bettina; Denzlinger, Claudio; Giessen-Jung, Clemens; Stahler, Arndt; Michl, Marlies; Held, Swantje; Jung, Andreas; Kirchner, Thomas; Stintzing, Sebastian und Heinemann, Volker
(2021):
Gender-dependent survival benefit from first-line irinotecan in metastatic colorectal cancer. Subgroup analysis of a phase III trial (XELAVIRI-study, AIO-KRK-0110).
In: European Journal of Cancer, Bd. 147: S. 128-139
Thurmaier, Johannes; Heinemann, Volker; Engel, Jutta; Schubert‐Fritschle, Gabriele; Wiedemann, Max; Nüssler, Natascha C.; Ruppert, Reinhard; Kleeff, Jörg; Schepp, Wolfgang; Löhe, Florian; Karthaus, Meinolf; Neumann, Jens; Kumbrink, Jörg; Taverna, Francesco; Stahler, Arndt ORCID: https://orcid.org/0000-0003-1041-0137; Heinrich, Kathrin; Westphalen, Christoph Benedikt; Holch, Julian W.; Kirchner, Thomas und Michl, Marlies
(28. Oktober 2020):
Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survival.
In: International Journal of Cancer, Bd. 148, Nr. 8: S. 1919-1927
[PDF, 619kB]
ORCID: https://orcid.org/0000-0003-1041-0137; Heinrich, Kathrin; Westphalen, Christoph Benedikt; Holch, Julian W.; Kirchner, Thomas und Michl, Marlies
(28. Oktober 2020):
Patients with colorectal cancer and brain metastasis: The relevance of extracranial metastatic patterns predicting time intervals to first occurrence of intracranial metastasis and survival.
In: International Journal of Cancer, Bd. 148, Nr. 8: S. 1919-1927
[PDF, 619kB]
Modest, Dominik Paul; Heinemann, Volker; Folprecht, Gunnar; Denecke, Timm; Pratschke, Johann; Lang, Hauke; Bemelmans, Marc; Becker, Thomas; Rentsch, Markus; Seehofer, Daniel; Bruns, Christiane J.; Gebauer, Bernhard; Held, Swantje; Stahler, Arndt; Heinrich, Kathrin; Einem, Jobst C. von; Stintzing, Sebastian; Neumann, Ulf P. und Ricard, Ingrid
(2020):
Factors That Influence Conversion to Resectability and Survival After Resection of Metastases in RAS WT Metastatic Colorectal Cancer (mCRC): Analysis of FIRE-3-AIOKRK0306.
In: Annals of Surgical Oncology, Bd. 27, Nr. 7: S. 2389-2401
Stahler, Arndt; Stintzing, Sebastian; Modest, Dominik P.; Ricard, Ingrid; Giessen-Jung, Clemens; Kapaun, Christine; Ivanova, Boryana; Kaiser, Florian; Fischer von Weikersthal, Ludwig; Moosmann, Nicolas; Schalhorn, Andreas; Stauch, Martina; Kiani, Alexander; Held, Swantje; Decker, Thomas; Moehler, Markus; Neumann, Jens; Kirchner, Thomas; Jung, Andreas und Heinemann, Volker
(2020):
Amphiregulin Expression Is a Predictive Biomarker for EGFR Inhibition in Metastatic Colorectal Cancer: Combined Analysis of Three Randomized Trials.
In: Clinical Cancer Research, Bd. 26, Nr. 24: S. 6559-6567
Stahler, Arndt; Stintzing, Sebastian; Einem, Jobst C. von; Westphalen, Christoph B.; Heinrich, Kathrin; Kraemer, Nicole; Michl, Marlies; Modest, Dominik P.; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kiani, Alexander; Heintges, Tobias; Kahl, Christoph; Kullmann, Frank; Scheithauer, Werner; Moehler, Markus; Kaiser, Florian; Kirchner, Thomas; Jung, Andreas und Heinemann, Volker
(2020):
Single-nucleotide variants, tumour mutational burden and microsatellite instability in patients with metastatic colorectal cancer: Next-generation sequencing results of the FIRE-3 trial.
In: European Journal of Cancer, Bd. 137: S. 250-259
Kurreck, Annika; Heinemann, Volker; Fischer von Weikersthal, Ludwig; Decker, Thomas; Kaiser, Florian; Uhlig, Jens; Schenk, Michael; Freiberg-Richter, Jens; Peuser, Bettina; Denzlinger, Claudio; Graeven, Ullrich; Schwaner, Ingo; Stahler, Arndt; Heinrich, Kathrin; Jung, Andreas; Held, Swantje; von Einem, Jobst C.; Stintzing, Sebastian; Giessen-Jung, Clemens und Modest, Dominik P.
(2020):
Impact of age on efficacy and early mortality of initial sequential treatment versus upfront combination chemotherapy in patients with metastatic colorectal cancer: a subgroup analysis of a phase III trial (AIO KRK0110, XELAVIRI study).
In: European Journal of Cancer, Bd. 137: S. 81-92
Stahler, Arndt ORCID: https://orcid.org/0000-0003-1041-0137; Heinemann, Volker; Ricard, Ingrid; Einem, Jobst C. von; Giessen-Jung, Clemens; Westphalen, Christoph Benedikt; Michl, Marlies; Heinrich, Kathrin; Miller-Phillips, Lisa; Jelas, Ivan; Stintzing, Sebastian und Modest, Dominik Paul
(2020):
Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials.
In: Journal of cancer research and clinical oncology, Bd. 146, Nr. 8: S. 2077-2087
[PDF, 1MB]
ORCID: https://orcid.org/0000-0003-1041-0137; Heinemann, Volker; Ricard, Ingrid; Einem, Jobst C. von; Giessen-Jung, Clemens; Westphalen, Christoph Benedikt; Michl, Marlies; Heinrich, Kathrin; Miller-Phillips, Lisa; Jelas, Ivan; Stintzing, Sebastian und Modest, Dominik Paul
(2020):
Current treatment options in RAS mutant metastatic colorectal cancer patients: a meta-analysis of 14 randomized phase III trials.
In: Journal of cancer research and clinical oncology, Bd. 146, Nr. 8: S. 2077-2087
[PDF, 1MB]
Modest, Dominik Paul; Fischer von Weikersthal, Ludwig; Decker, Thomas; Vehling-Kaiser, Ursula; Uhlig, Jens; Schenk, Michael; Freiberg-Richter, Jens; Peuser, Bettina; Denzlinger, Claudio; Reddemann, Christina Peveling Genannt; Graeven, Ullrich; Schuch, Gunter; Schwaner, Ingo; Stahler, Arndt; Jung, Andreas; Kirchner, Thomas; Held, Swantje; Stintzing, Sebastian; Giessen-Jung, Clemens und Heinemann, Volker
(2019):
Sequential Versus Combination Therapy of Metastatic Colorectal Cancer Using Fluoropyrimidines, Irinotecan, and Bevacizumab: A Randomized, Controlled StudyXELAVIRI (AIO KRK0110).
In: Journal of Clinical Oncology, Bd. 37, Nr. 1
Stahler, Arndt; Heinemann, Volker; Neumann, Jens; Crispin, Alexander; Schalhorn, Andreas; Stintzing, Sebastian; Giessen-Jung, Clemens; Fischer von Weikersthal, Ludwig; Vehling-Kaiser, Ursula; Stauch, Martina; Quietzsch, Detlef; Holch, Julian W.; Kruger, Stephan; Haas, Michael; Michl, Marlies; Einem, Jobst von; Kirchner, Thomas; Jung, Andreas und Modest, Dominik P.
(2017):
Prevalence and influence on outcome of HER2/neu, HER3 and NRG1 expression in patients with metastatic colorectal cancer.
In: Anti-cancer drugs, Bd. 28, Nr. 7: S. 717-722
[PDF, 422kB]